These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1540981)

  • 1. Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate.
    Haisma HJ; Boven E; van Muijen M; De Vries R; Pinedo HM
    Cancer Immunol Immunother; 1992; 34(5):343-8. PubMed ID: 1540981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.
    Senter PD; Saulnier MG; Schreiber GJ; Hirschberg DL; Brown JP; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4842-6. PubMed ID: 3387440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates.
    Senter PD; Schreiber GJ; Hirschberg DL; Ashe SA; Hellström KE; Hellström I
    Cancer Res; 1989 Nov; 49(21):5789-92. PubMed ID: 2790791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs.
    Blakey DC; Davies DH; Dowell RI; East SJ; Burke PJ; Sharma SK; Springer CJ; Mauger AB; Melton RG
    Br J Cancer; 1995 Nov; 72(5):1083-8. PubMed ID: 7577451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase.
    Jeppsson A; Wahren B; Millán JL; Stigbrand T
    Br J Cancer; 1984 Feb; 49(2):123-8. PubMed ID: 6365130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.
    Sahin U; Hartmann F; Senter P; Pohl C; Engert A; Diehl V; Pfreundschuh M
    Cancer Res; 1990 Nov; 50(21):6944-8. PubMed ID: 2170012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.
    Francis RJ; Sharma SK; Springer C; Green AJ; Hope-Stone LD; Sena L; Martin J; Adamson KL; Robbins A; Gumbrell L; O'Malley D; Tsiompanou E; Shahbakhti H; Webley S; Hochhauser D; Hilson AJ; Blakey D; Begent RH
    Br J Cancer; 2002 Sep; 87(6):600-7. PubMed ID: 12237768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells.
    Kim KY; Cho YJ; Jeon GA; Ryu PD; Myeong JN
    Mol Cell Biochem; 2003 Oct; 252(1-2):213-21. PubMed ID: 14577595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.
    Haisma HJ; Boven E; van Muijen M; de Jong J; van der Vijgh WJ; Pinedo HM
    Br J Cancer; 1992 Sep; 66(3):474-8. PubMed ID: 1520585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.
    Rogers GT; Burke PJ; Sharma SK; Koodie R; Boden JA
    Br J Cancer; 1995 Dec; 72(6):1357-63. PubMed ID: 8519645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
    Pedley RB; Sharma SK; Boxer GM; Boden R; Stribbling SM; Davies L; Springer CJ; Begent RH
    Cancer Res; 1999 Aug; 59(16):3998-4003. PubMed ID: 10463598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
    Deckert PM; Bornmann WG; Ritter G; Williams C; Franke J; Keilholz U; Thiel E; Old LJ; Bertino JR; Welt S
    Int J Oncol; 2004 May; 24(5):1289-95. PubMed ID: 15067353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
    Stribbling SM; Martin J; Pedley RB; Boden JA; Sharma SK; Springer CJ
    Cancer Chemother Pharmacol; 1997; 40(4):277-84. PubMed ID: 9225945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material.
    Webley SD; Francis RJ; Pedley RB; Sharma SK; Begent RH; Hartley JA; Hochhauser D
    Br J Cancer; 2001 Jun; 84(12):1671-6. PubMed ID: 11401322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy.
    Sharma SK; Bagshawe KD; Burke PJ; Boden JA; Rogers GT; Springer CJ; Melton RG; Sherwood RF
    Cancer; 1994 Feb; 73(3 Suppl):1114-20. PubMed ID: 8306255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
    Boxer GM; Abassi AM; Pedley RB; Begent RH
    Br J Cancer; 1994 Feb; 69(2):307-14. PubMed ID: 7507692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
    de Jong RS; Slijfer EA; Uges DR; Mulder NH; de Vries EG
    Br J Cancer; 1997; 76(11):1480-3. PubMed ID: 9400945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
    Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T
    Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans.
    Oriuchi N; Watanabe N; Kanda H; Hashimoto M; Sugiyama S; Takenoshita S; Imai K; Ueda R; Endo K
    Cancer Immunol Immunother; 1998 Aug; 46(6):311-7. PubMed ID: 9756415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.